Constipation is a recognised adverse effect listed in the Summary of Product Characteristics for all GLP-1 medications
According to the American Diabetes Association (ADA) Standards of Care, a GLP-1 RA should be considered in T2D patients who have not met glycemic goals on metformin, especially if additional factors are present such as atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease
Novel dual agonists that can enter the brain more easily show good first results in preclinical studies and have entered clinical trials
Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Semabest (Semaglutide) Injection in India
Our team at Boca Medical Care is dedicated to identifying suitable candidates for Tirzepatide
Decrease Insulin Resistance: Insulin resistance is a condition in which the bodys cells become less responsive to the effects of insulin